Innospec Stock Today
| IOSP Stock | USD 76.28 0.26 0.34% |
PerformanceWeakest
| Odds Of DistressLow
|
Innospec is selling at 76.28 as of the 5th of January 2026; that is 0.34 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 75.4. Innospec has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 6th of November 2025 and ending today, the 5th of January 2026. Click here to learn more.
Business Domain Materials | IPO Date 13th of May 1998 | Category Basic Materials |
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. The company has 24.78 M outstanding shares of which 427.47 K shares are currently shorted by private and institutional investors with about 1.39 trading days to cover. More on Innospec
Moving together with Innospec Stock
Moving against Innospec Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Innospec Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Patrick Williams | ||||
| Business Concentration | Specialty Chemicals, Basic Materials, NASDAQ Composite, SP Small-Cap 600, Nasdaq Industrial, NASDAQ Composite Total, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsInnospec can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Innospec's financial leverage. It provides some insight into what part of Innospec's total assets is financed by creditors.
| |||||
Innospec (IOSP) is traded on NASDAQ Exchange in USA and employs 2,450 people. Innospec is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.89 B. Innospec conducts business under Chemicals sector and is part of Materials industry. The entity has 24.78 M outstanding shares of which 427.47 K shares are currently shorted by private and institutional investors with about 1.39 trading days to cover.
Innospec currently holds about 71.4 M in cash with 184.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.88.
Check Innospec Probability Of Bankruptcy
Ownership AllocationInnospec has a total of 24.78 Million outstanding shares. The majority of Innospec outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innospec to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innospec. Please pay attention to any change in the institutional holdings of Innospec as this could imply that something significant has changed or is about to change at the company. Also note that almost one hundred twenty-eight thousand eight hundred fourty-three invesors are currently shorting Innospec expressing very little confidence in its future performance.
Check Innospec Ownership Details
Innospec Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Charles Schwab Investment Management Inc | 2025-06-30 | 356.2 K | |
| Millennium Management Llc | 2025-06-30 | 350 K | |
| Jpmorgan Chase & Co | 2025-06-30 | 321.2 K | |
| Qube Research & Technologies | 2025-06-30 | 306.8 K | |
| Northern Trust Corp | 2025-06-30 | 302.5 K | |
| Nuveen, Llc | 2025-06-30 | 296 K | |
| Bank Of America Corp | 2025-06-30 | 295.5 K | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 263.8 K | |
| Hhg Plc | 2025-06-30 | 255.4 K | |
| Blackrock Inc | 2025-06-30 | 3.7 M | |
| Vanguard Group Inc | 2025-06-30 | 3.2 M |
Innospec Historical Income Statement
Innospec Stock Against Markets
Innospec Corporate Management
| David CPA | General VP | Profile | |
| Trey Griffin | Senior Resources | Profile | |
| Graeme Blair | Head Finance | Profile | |
| Corbin Barnes | Senior Relations | Profile |
Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.